Avistone Announces Interim Data Results on PLB1004 in Patients with EGFR mutant NSCLC Patients at AACR 2023
BEIJING--(BUSINESS WIRE)--Avistone Biotechnology (“Avistone” or “the Company”), a clinical-stage biotechnology company focused on precision oncology…